Smith & Nephew to buy Healthpoint Biotherapeutics

theflyonthewall.com

Smith & Nephew (SNN) today announced that it entered into an agreement through its subsidiaries to acquire substantially all the assets of Healthpoint Biotherapeutics, a leader in bioactive debridement, dermal repair and regeneration wound care treatments, for $782M in cash.

Rates

View Comments (0)